320 related articles for article (PubMed ID: 11786416)
1. Lipoprotein(a) promotes smooth muscle cell proliferation and dedifferentiation in atherosclerotic lesions of human apo(a) transgenic rabbits.
Ichikawa T; Unoki H; Sun H; Shimoyamada H; Marcovina S; Shikama H; Watanabe T; Fan J
Am J Pathol; 2002 Jan; 160(1):227-36. PubMed ID: 11786416
[TBL] [Abstract][Full Text] [Related]
2. Transgenic rabbits expressing human apolipoprotein(a) develop more extensive atherosclerotic lesions in response to a cholesterol-rich diet.
Fan J; Shimoyamada H; Sun H; Marcovina S; Honda K; Watanabe T
Arterioscler Thromb Vasc Biol; 2001 Jan; 21(1):88-94. PubMed ID: 11145938
[TBL] [Abstract][Full Text] [Related]
3. Lipoprotein(a), plasmin modulation, and atherogenesis.
Harpel PC; Hermann A; Zhang X; Ostfeld I; Borth W
Thromb Haemost; 1995 Jul; 74(1):382-6. PubMed ID: 8578490
[TBL] [Abstract][Full Text] [Related]
4. Diversity of the synthetic-state smooth-muscle cells proliferating in mechanically and hemodynamically injured rabbit arteries.
Okamoto E; Suzuki T; Aikawa M; Imataka K; Fujii J; Kuro-o M; Nakahara K; Hasegawa A; Yazaki Y; Nagai R
Lab Invest; 1996 Jan; 74(1):120-8. PubMed ID: 8569174
[TBL] [Abstract][Full Text] [Related]
5. Lipoprotein(a) enhances advanced atherosclerosis and vascular calcification in WHHL transgenic rabbits expressing human apolipoprotein(a).
Sun H; Unoki H; Wang X; Liang J; Ichikawa T; Arai Y; Shiomi M; Marcovina SM; Watanabe T; Fan J
J Biol Chem; 2002 Dec; 277(49):47486-92. PubMed ID: 12196525
[TBL] [Abstract][Full Text] [Related]
6. Activation of transforming growth factor-beta is inhibited in transgenic apolipoprotein(a) mice.
Grainger DJ; Kemp PR; Liu AC; Lawn RM; Metcalfe JC
Nature; 1994 Aug; 370(6489):460-2. PubMed ID: 8047165
[TBL] [Abstract][Full Text] [Related]
7. Lipoprotein(a) stimulates the proliferation of cultured human arterial smooth muscle cells through two pathways.
Miyata M; Biro S; Kaieda H; Tanaka H
FEBS Lett; 1995 Dec; 377(3):493-6. PubMed ID: 8549783
[TBL] [Abstract][Full Text] [Related]
8. An apolipoprotein(a) peptide delays chylomicron remnant clearance and increases plasma remnant lipoproteins and atherosclerosis in vivo.
Devlin CM; Lee SJ; Kuriakose G; Spencer C; Becker L; Grosskopf I; Ko C; Huang LS; Koschinsky ML; Cooper AD; Tabas I
Arterioscler Thromb Vasc Biol; 2005 Aug; 25(8):1704-10. PubMed ID: 15905467
[TBL] [Abstract][Full Text] [Related]
9. Proliferation of human smooth muscle cells promoted by lipoprotein(a).
Grainger DJ; Kirschenlohr HL; Metcalfe JC; Weissberg PL; Wade DP; Lawn RM
Science; 1993 Jun; 260(5114):1655-8. PubMed ID: 8503012
[TBL] [Abstract][Full Text] [Related]
10. [Lipoprotein (a)--a mysterious factor in atherogenesis].
Jelaković B; Laganović M; Kuzmanić D
Lijec Vjesn; 2002; 124(11-12):366-71. PubMed ID: 12679978
[TBL] [Abstract][Full Text] [Related]
11. Atherogenesis in transgenic mice with human apolipoprotein B and lipoprotein (a).
Callow MJ; Verstuyft J; Tangirala R; Palinski W; Rubin EM
J Clin Invest; 1995 Sep; 96(3):1639-46. PubMed ID: 7657833
[TBL] [Abstract][Full Text] [Related]
12. Lipoprotein(a) as a risk factor for atherosclerosis and thrombosis: mechanistic insights from animal models.
Boffa MB; Marcovina SM; Koschinsky ML
Clin Biochem; 2004 May; 37(5):333-43. PubMed ID: 15087247
[TBL] [Abstract][Full Text] [Related]
13. Effect of fluvastatin sodium on the smooth muscle cells in atherosclerotic plaques. In vivo study using low-density lipoprotein receptor deficient Watanabe heritable hyperlipidemic (WHHL) rabbits.
Shiomi M; Ito T; Tsukada T; Shiraishi M; Yata T
Arzneimittelforschung; 1998 Jun; 48(6):680-5. PubMed ID: 9689427
[TBL] [Abstract][Full Text] [Related]
14. Lipid lowering promotes accumulation of mature smooth muscle cells expressing smooth muscle myosin heavy chain isoforms in rabbit atheroma.
Aikawa M; Rabkin E; Voglic SJ; Shing H; Nagai R; Schoen FJ; Libby P
Circ Res; 1998 Nov; 83(10):1015-26. PubMed ID: 9815149
[TBL] [Abstract][Full Text] [Related]
15. Human smooth muscle myosin heavy chain isoforms as molecular markers for vascular development and atherosclerosis.
Aikawa M; Sivam PN; Kuro-o M; Kimura K; Nakahara K; Takewaki S; Ueda M; Yamaguchi H; Yazaki Y; Periasamy M
Circ Res; 1993 Dec; 73(6):1000-12. PubMed ID: 7916668
[TBL] [Abstract][Full Text] [Related]
16. Smooth muscle phenotypes in developing and atherosclerotic human arteries demonstrated by myosin expression.
Aikawa M; Yamaguchi H; Yazaki Y; Nagai R
J Atheroscler Thromb; 1995; 2(1):14-23. PubMed ID: 9225203
[TBL] [Abstract][Full Text] [Related]
17. Atherogenesis in transgenic mice expressing human apolipoprotein(a).
Lawn RM; Wade DP; Hammer RE; Chiesa G; Verstuyft JG; Rubin EM
Nature; 1992 Dec; 360(6405):670-2. PubMed ID: 1465128
[TBL] [Abstract][Full Text] [Related]
18. Lipoprotein Lp(a) and atherothrombotic disease.
de la Peña-Díaz A; Izaguirre-Avila R; Anglés-Cano E
Arch Med Res; 2000; 31(4):353-9. PubMed ID: 11068075
[TBL] [Abstract][Full Text] [Related]
19. Structural basis for the pathophysiology of lipoprotein(a) in the athero-thrombotic process.
Anglés-Cano E
Braz J Med Biol Res; 1997 Nov; 30(11):1271-80. PubMed ID: 9532233
[TBL] [Abstract][Full Text] [Related]
20. Assembly of lipoprotein (a) in transgenic rabbits expressing human apolipoprotein (a).
Fan J; Araki M; Wu L; Challah M; Shimoyamada H; Lawn RM; Kakuta H; Shikama H; Watanabe T
Biochem Biophys Res Commun; 1999 Feb; 255(3):639-44. PubMed ID: 10049763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
